Tanycyte-Derived Lactate Activates Astrocytic HCAR1 to Modulate Glutamatergic Signaling and POMC Neuron Excitability

For decades, the prevailing scientific narrative regarding the brain’s intricate control over appetite has predominantly centered on neurons, the specialized cells responsible for transmitting electrical and chemical signals. However, groundbreaking research is progressively dismantling this singular focus, revealing a far more complex and interconnected neural ecosystem where other cell types, long relegated to supporting roles, are emerging as pivotal regulators of fundamental biological processes, including our very perception of hunger and satiety. A landmark study, published in the prestigious Proceedings of the National Academy of Sciences on April 6, 2026, offers compelling evidence that astrocytes, a class of glial cells historically considered mere structural and metabolic caretakers for neurons, may in fact wield a far more active and direct influence on appetite regulation than previously understood.

This significant advancement is the culmination of nearly a decade of meticulous research and international collaboration, primarily between scientists at the University of Concepción in Chile and their colleagues at the University of Maryland. Their joint efforts have illuminated a previously unrecognized signaling pathway situated within the hypothalamus, the brain’s command center for regulating a vast array of vital functions, including hunger, thirst, body temperature, and sleep-wake cycles. The discovery of this novel pathway, involving the intricate interplay between tanycytes, astrocytes, and neurons, has profound implications for understanding and potentially treating a spectrum of metabolic disorders, most notably obesity and various eating disorders that afflict millions worldwide.

Rethinking Brain Communication: The Astrocytic Revolution

"There’s a common misconception that when we talk about brain function, we are solely discussing neurons," stated Ricardo Araneda, a distinguished professor in the Department of Biology at the University of Maryland and a corresponding author of the study. "However, our findings are increasingly demonstrating that astrocytes, which we historically viewed as passive support cells, are actively participating in the brain’s sophisticated mechanisms for regulating food intake. This research fundamentally reshapes our understanding of these communication circuits and the cellular players involved."

The research meticulously details a cascade of events initiated by specialized cells known as tanycytes. These unique cells are strategically positioned along the walls of a fluid-filled cavity deep within the brain, a location that grants them direct access to the cerebrospinal fluid. Their critical function involves continuously monitoring the levels of glucose, the primary fuel source for the body’s cells, as it circulates through this vital fluid.

The Post-Meal Glucose Signal: A Chain of Events

Following a meal, the body’s physiological response includes a predictable rise in blood glucose levels, which is mirrored by an increase in glucose concentration within the cerebrospinal fluid. Tanycytes are exquisitely sensitive to these fluctuations. Upon detecting elevated glucose, they initiate a metabolic process where they metabolize the sugar and, in turn, release lactate, a byproduct of this cellular respiration, into the surrounding brain tissue. This released lactate then acts as a crucial signaling molecule, interacting with neighboring astrocytes.

Historically, scientific understanding posited that lactate produced by tanycytes acted as a direct messenger, communicating with neurons specifically involved in the complex circuitry that governs appetite. However, the current study reveals a more nuanced and elaborate communication system. "Researchers previously believed that the lactate released by tanycytes directly ‘spoke’ to the neurons responsible for appetite control," Araneda explained. "What we have uncovered is an unexpected intermediary in this crucial conversation: the astrocytes."

Astrocytes: More Than Just Support Staff

Astrocytes, which constitute the most abundant cell type in the brain, have long been characterized by their supportive functions, including providing metabolic support, maintaining the blood-brain barrier, and modulating synaptic transmission. This new research, however, unequivocally demonstrates their capacity to engage in direct and active signaling, playing a much more dynamic role in neural communication than previously appreciated.

The study identified a specific receptor on the surface of astrocytes, known as HCAR1 (Hydroxycarboxylic acid receptor 1). This receptor is highly adept at detecting and binding to lactate. When lactate molecules from the tanycytes bind to HCAR1 on astrocytes, it triggers a significant activation of these glial cells. This activation, in turn, prompts the astrocytes to release glutamate, a ubiquitous excitatory neurotransmitter in the central nervous system. This glutamate signal is then transmitted to specific populations of neurons within the hypothalamus that are known to suppress appetite, thereby contributing to the physiological sensation of fullness and satiety.

"The level of complexity we uncovered was truly surprising," Araneda elaborated. "To simplify it for a broader understanding, we found a sequential communication pathway: tanycytes ‘talk’ to astrocytes, and subsequently, astrocytes ‘talk’ to neurons." This elegant intercellular dialogue highlights a sophisticated regulatory mechanism that fine-tunes our eating behavior.

A Rippling Effect: Spreading Signals Through the Neural Network

Experimental evidence further underscores the widespread impact of this signaling pathway. In one key experiment, researchers precisely introduced glucose into a single tanycyte and meticulously observed the activity of surrounding astrocytes. The results were striking: even this highly localized metabolic change in a single tanycyte was sufficient to elicit a measurable increase in activity across multiple adjacent astrocytes. This observation vividly illustrates the potential for signals to propagate and amplify throughout the brain’s interconnected neural networks, influencing a broader neuronal response.

Furthermore, the research suggests a potential dual role for lactate in modulating hypothalamic neuronal activity. "We also observed what appears to be a dual effect," Araneda noted. "The hypothalamus contains two opposing populations of neurons: those that stimulate hunger and those that inhibit it. Our findings suggest that lactate might act on both simultaneously. It appears to activate the neurons that promote fullness, acting through astrocytes, while potentially also influencing the hunger-promoting neurons through a more direct, albeit yet fully elucidated, route." This dual action could provide a highly efficient mechanism for rapidly adjusting appetite signals in response to nutrient availability.

Therapeutic Horizons: Targeting Appetite Dysregulation

While the study was conducted using animal models, the fundamental cellular components – tanycytes and astrocytes – are conserved across all mammalian species, including humans. This remarkable conservation strongly suggests that the newly identified signaling pathway and its regulatory mechanisms are likely operational in the human brain as well, paving the way for potential therapeutic applications.

The immediate next step for the research team involves a critical experimental validation: investigating whether manipulating the HCAR1 receptor on astrocytes can directly influence eating behavior in their animal models. This line of inquiry is considered essential for establishing the receptor as a viable therapeutic target before any translation to human treatments can be considered.

Currently, no pharmaceutical interventions directly target this specific astrocytic-neuronal pathway. However, Professor Araneda expresses significant optimism regarding its therapeutic potential. "We have now identified a novel mechanism through which we could potentially intervene, either by targeting astrocytes themselves or, more specifically, the HCAR1 receptor," he stated. "This represents a promising new avenue that could complement existing therapeutic strategies, such as those employed by drugs like Ozempic, and significantly improve the quality of life for individuals struggling with obesity and other appetite-related conditions."

A Decade of Collaborative Scientific Endeavor

The groundbreaking findings presented in this study are the product of an extraordinary, long-term scientific collaboration that spanned nearly ten years. This ambitious project brought together the expertise and resources of Professor Araneda’s laboratory at the University of Maryland and the research group led by Dr. María de los Ángeles García-Robles at the University of Concepción, who served as the principal investigator for the project.

Crucially, the lead author of the published paper, Sergio López, a doctoral student who benefited from co-mentorship by both researchers, conducted the pivotal experiments during an extended eight-month research visit to the University of Maryland. This immersive period was instrumental in bringing the complex experimental designs to fruition.

The paper detailing these significant discoveries, titled "Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability," was formally published in the Proceedings of the National Academy of Sciences on April 6, 2026.

This extensive research initiative received vital financial support from several key organizations. Funding was provided by Chile’s National Fund for Scientific and Technological Development, the Millennium Institute of Neuroscience in Valparaíso, and the U.S. National Institutes of Health (under Award No. R01AG088147A). It is important to note that the views expressed in this article are those of the researchers and do not necessarily reflect the official positions or policies of these funding bodies. The implications of this research are far-reaching, promising a paradigm shift in our understanding of brain function and opening new avenues for the treatment of debilitating metabolic and eating disorders.